Skip to content

Assessment of Bone Mineral Density During Pregnancy

Changes in Bone Mineral Density as Measured by Calcaneal Quantitative Ultrasound in Third Trimester of Pregnancy

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02480023
Enrollment
173
Registered
2015-06-24
Start date
2015-06-30
Completion date
2016-01-31
Last updated
2016-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Mineral Density Quantitative Trait Locus 3

Brief summary

BMD at peripheral sites typically heel is measured by Ultrasound densitometry at Ain Shams Maternity hospital.

Detailed description

Consecutive patients with singleton pregnancies between 36 and 39 weeks booked at a general obstetric clinic in a regional hospital will be recruited for the study. The obstetric department is a tertiary referral center in the region and part of a university teaching unit which catered to an annual delivery of around 10,000 women. A group of first trimester pregnant women with nearly the same age is recruited as controls.

Interventions

RADIATIONcalcaneal quantitative ultrasound assessment

QUS for calcaneus bone of right foot will be done for this group of Pregnant women at the third trimester

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

1\. females during 3rd trimister

Exclusion criteria

1. Secondary causes of bone loss such as hyperparathyroidism. 2. Co-morbidities that would interfere with bone metabolism as clinically significant liver or renal disease. 3. Physical or orthopedic disabilities that would place the subject at risk or limit their ability to perform US. 4. Taking medication known to affect bone including steroid hormones. Histories of smoking and use of oral contraceptives (OCs) are not

Design outcomes

Primary

MeasureTime frame
Bone mineral density loss during pregnancy that is detectable by quantitative ultrasound at the os calcis.6 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026